Announcement of Resolutions of the 2025 Annual Shareholders Meeting of Fujian Aonong Biotechnology Group Co., Ltd.
Securities code: 603363 Securities abbreviation: Aonong Biotechnology Announcement number: 2026-043 Fujian Aonong Biotechnology Group Co., Ltd.
Announcement of Resolutions of the 2025 Annual Shareholders Meeting
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the announcement content, and assume legal responsibility for the authenticity, accuracy and completeness of its content.
Important content reminder:
Is there any veto resolution at this meeting: None
1. Meeting convening and attendance
(1) Time of the shareholders’ meeting: June 16, 2026
(2) The location of the shareholders’ meeting: the intersection of Xingting Road and Baolian Road, Shiting Town, Xiangcheng District, Zhangzhou City, Fujian Province
Fujian Aonong Conference Room
(3) Common shareholders attending the meeting and preference shareholders whose voting rights have been restored and their holdings:
Number of shareholders and proxies attending the meeting 1,056
Total number of shares with voting rights held by shareholders attending the meeting (shares) 852,078,696
The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares.
Proportion of total number of copies (%) 34.2374
(4) Whether the voting method complies with the provisions of the "Company Law" and the "Articles of Association", the status of the meeting, etc. This annual shareholders' meeting was convened by the company's board of directors and chaired by Chairman Su Mingcheng. The meeting was held and voted by a combination of on-site voting and online voting. The convening, holding and voting methods of the meeting comply with the provisions of the Company Law and the Articles of Association.
(5) Attendance of company directors and board secretary
- The company has 9 current directors and 5 are present, including directors Cai Jiangfu, Li Haozhe, Li Jinglong and Chen Mingyiyin
Unable to attend this meeting due to work reasons;
- Yang Zhou, deputy general manager and chief financial officer, and Peng Jiang, deputy general manager and secretary of the board of directors, attended this meeting.
2. Proposal review status
(1) Non-cumulative voting proposals
- Proposal Name: 2025 Board of Directors Work Report
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 844,920,749 99.1599 5,855,147 0.6872 1,302,800 0.1529
- Proposal name: The company’s 2025 annual report and its summary
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 845,124,476 99.1839 5,777,820 0.6781 1,176,400 0.1381
- Proposal Name: 2025 Financial Final Account Report and 2026 Financial Budget Plan
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 844,963,166 99.1649 5,764,730 0.6765 1,350,800 0.1585
- Proposal Name: 2025 Profit Distribution Plan
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 843,738,849 99.0212 6,683,057 0.7843 1,656,790 0.1944
- Proposal Name: Proposal on the Company’s Uncovered Losses Reaching One-third of the Total Paid-in Share Capital
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%) A shares 843,844,066 99.0336 6,409,430 0.7522 1,825,200 0.2142
- Proposal name: Review results of the proposal on formulating the "Remuneration Management System for Directors and Senior Management Personnel": Passed
Voting status:
Agree Objection Abstaining shareholder type Proportion Proportion Number of votes Number of votes Number of votes
(%) (%) (%) A shares 843,430,449 98.9850 7,123,547 0.8360 1,524,700 0.1789
(2) When major matters are involved, the voting status of shareholders below 5%
- Non-cumulative voting proposals
Agree Objection Abstain motion
Motion name Proportion Proportion number Number of votes Number of votes Number of votes
(%) (%) (%)4 Profit for the year 2025 103,8
6,683 1,656
Distribution plan 37,87 92.5655 5.9576 1.4769
,057 ,790
6 Regarding the formulation of the "Director's
103,5
Directors and senior managers 7,123 1,524
29,47 92.2906 6.3502 1.3592 employee salary management system, 547,700
"degree" motion
(3) Explanation of relevant circumstances regarding voting on motions
The proposals at this meeting are non-related proposals and do not involve related shareholders.
All motions at this meeting were passed.
The shareholders' meeting also listened to the company's independent directors' "2025 Independent Directors' Work Report"
3. Lawyer’s testimony
(1) Law firm witnessing this shareholder meeting: Beijing Zhonglun Law Firm
Lawyers: Jin Huanji, Geng Jiayi
(2) Lawyer’s concluding comments:
The convening and convening procedures of the company's shareholders' meeting, the qualifications of the attendees and conveners, and the voting procedures of the meeting are all in compliance with the relevant provisions of the "Company Law of the People's Republic of China", "Rules of Shareholders' Meetings of Listed Companies" and other laws, regulations, normative documents and the "Articles of Association", and the voting results are legal and valid.
Announcement is hereby made.
Board of Directors of Fujian Aonong Biotechnology Group Co., Ltd.
June 17, 2026